[PRNewswire] Taimei Technology opens Singapore office to support digital
전체 맥락을 이해하기 위해서는 본문 보기를 권장합니다.
Taimei Technology vice president, general manager of clinical research BU and APAC head Nate Zhang added, "Taimei Technology continues to implement its strategy of advancing platform-based clinical research by providing global customers with higher-quality services. With the TrialOS platform, we expect to further our collaboration with local customers and partners with the aim of accelerating the adoption of advanced digital technologies used in clinical research, improving the efficiency of clinical research operations, and speeding up the R&D of new drugs to benefit more patients by providing them with easier access to effective and affordable drugs."
본고는 자료 제공사에서 제공한 것으로, 연합뉴스는 내용에 대해 어떠한 편집도 하지 않았음을 밝혀 드립니다.
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
transformation of clinical research in APAC
(SHANGHAI, Feb. 7, 2023 PRNewswire=연합뉴스) China-based Taimei Technology, a digital cooperation platform for the life science industry, announced the opening of its new office in Singapore on February 1, 2023. The office, strategically located in one of the world's financial centres as well as one of APAC's economic and cultural centres, is expected to help accelerate the adoption of the company's innovative digital technologies for clinical research across the region and provide local customers with better services and experience with the support of local resources, while working with Taimei's partners to improve the application of digital technologies in regional clinical research and empower pharmaceutical innovations.
Representatives from more than 20 organizations, including Integrated Health Information Systems (IHiS, an agency closely affiliated with Singapore's Ministry of Health (MOH)), National Healthcare Group (NHG), SingHealth, Singapore Clinical Research Institute (SCRI) and CSI Medical Research were invited to attend the opening ceremony for the new office.
Taimei Technology chairman and CEO Lu Zhao said in his speech, "Taimei Technology has been committed to empowering innovative drugS' R&D with digital technologies since its inception. With our Drug R&D Digital Cooperation Platform TrialOS, we have built a complete digital product system for clinical research and pharmacovigilance. Looking ahead, Taimei Technology plans to focus on its growth by increasing its investments in the APAC market through the new Singapore office, and facilitate the implementation of additional collaborative projects."
Taimei Technology vice president, general manager of clinical research BU and APAC head Nate Zhang added, "Taimei Technology continues to implement its strategy of advancing platform-based clinical research by providing global customers with higher-quality services. With the TrialOS platform, we expect to further our collaboration with local customers and partners with the aim of accelerating the adoption of advanced digital technologies used in clinical research, improving the efficiency of clinical research operations, and speeding up the R&D of new drugs to benefit more patients by providing them with easier access to effective and affordable drugs."
Taimei Technology, a digital cooperation platform for the life science industry, and a market leader in the fields of digital clinical research, pharmacovigilance and pharmaceutical marketing, has become an important driver behind drug development breakthroughs in China. The company has established offices in the United States, Singapore, and the European Union, among other countries and regions, as it continues execute on its globalization roadmap in a move to support the development of new drugs worldwide through new digital technologies and practices for clinical research.
Taimei Technology has developed partnerships with CSI Medical Research and IHiS.
Source: Taimei Technology
[편집자 주] 본고는 자료 제공사에서 제공한 것으로, 연합뉴스는 내용에 대해 어떠한 편집도 하지 않았음을 밝혀 드립니다.
(끝)
출처 : PRNewswire 보도자료
Copyright © 연합뉴스 보도자료. 무단전재 및 재배포 금지.
- 이스라엘-이란 맞불 일단 '소강'…명분·체면 살리며 퇴로 찾나 | 연합뉴스
- 이란 턱밑까지 쿼드콥터? 미사일?…'발사체 정체' 놓고 신경전 | 연합뉴스
- 대통령실, '尹-이재명' 회담에 "아직 날짜·형식 미정" | 연합뉴스
- 북한, 한미 공군훈련중 '요격용' 신형 지대공미사일 시험 발사(종합2보) | 연합뉴스
- 장애인단체들, 장애인의날 한성대역 승강장 누워 '다이인' 시위 | 연합뉴스
- 비트코인 반감기 완료…가격 변동폭 일단 "안정적 유지"(종합) | 연합뉴스
- [위클리 스마트] 반도체 보조금 경쟁에 中 웃는다…"韓, 범용 반도체 키워야" | 연합뉴스
- 경제 불안에 국내 金 거래대금 '역대 최대'…한달새 2.4배 | 연합뉴스
- [지적장애인 홀로서기] ① "너도 할 수 있어" 아영씨의 '나 혼자 산다' | 연합뉴스
- 한은총재 "중동 확전 않는다면 환율 안정세 전환" | 연합뉴스